HOME >> MEDICINE >> NEWS
Bexxar highly effective as first-line treatment for patients with non-Hodgkin's lymphoma

Study shows radioactive antibodies produce durable remissions of three years or more

NEW ORLEANS - A radioactive antibody compound known as Bexxar produced tumor shrinkage in 97 percent of 76 previously untreated patients with advanced-stage, low-grade non-Hodgkins lymphoma (NHL) in a new study at the University of Michigan Comprehensive Cancer Center.

Most notably, 76 percent of patients achieved a complete remission, with no sign of cancer. In addition, 84 percent of patients with evidence of lymphoma at the molecular level at the start of the trial achieved molecular remission for as long as three years with the treatment. Molecular remissions were determined by a rigorous use of polymerase chain reaction, or PCR, technology, arguably the most sensitive cancer detection method available today.

These promising results, from the first completed study of a first-line, stand-alone radioimmunotherapy for cancer, were presented today at the meeting of the American Society of Clinical Oncology by Mark S. Kaminski, M.D., U-M professor of hematology/oncology and co-director of the U-M's leukemia/lymphoma and bone marrow transplant programs.

The original studies in the therapeutic development of Bexxar, or Iodine I 131 tositumomab, were done at the U-M by Kaminski and his colleague Richard Wahl, M.D., professor of nuclear medicine and radiology. The therapy is now being jointly developed by Coulter Pharmaceutical, Inc. and SmithKline Beecham.

"We are extremely excited by these findings, which showed remarkable response rates and molecular remissions lasting up to and beyond three years," says Kaminski. "Molecular remissions are seldom seen with chemotherapy in low-grade lymphoma, and appear to coincide with prolonged, durable responses. Furthermore, these results demonstrate the potential of this treatment as an effective and well-tolerated first-line, single-agent treatment for low-grade lymphoma, a disease without a known cure."


'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
21-May-2000


Page: 1 2 3

Related medicine news :

1. New highly active agents against sandfly fever
2. Engineers develop biowarfare sensing elements for future highly sensitive nerve-gas detectors
3. Patients with cancer have highly increased risk for blood clots
4. Inflammatory cells highly promising target in NF 1
5. Multi-center study finds therapy boosts kidney transplants in highly sensitized patients
6. Columbia Univ. Medical Center wins highly competitive stroke grant from NIH
7. Study showed vitamin D inadequacy highly prevalent among women treated for osteoporosis
8. World mental health surveys find mental disorders highly prevalent and often untreated
9. MRI highly useful in the evaluation of patients with uterine fibroids
10. 1st data show CRESTOR highly effective at lowering LDL-C in patients with type 2 diabetes
11. One in five asthmatics are highly sensitive to aspirin

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2020)... (PRWEB) , ... June 02, 2020 , ... ... and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health ... Information Officer. Mr. Lickfold succeeds John McGill, who, following a period of transition, ...
(Date:5/30/2020)... ... 2020 , ... In appreciation for all the dedication and hard work first ... offering a $500 bonus towards the lease or purchase of a new or unused ... 2021. , To qualify for this offer, individuals must be active as a police ...
(Date:5/28/2020)... GREENWICH, Conn. (PRWEB) , ... May 28, 2020 ... ... addition of an important new 7th Donor Shield protection. Donors can now be ... of the Donor Shield program. The other six Donor Shield protections include lost ...
(Date:5/27/2020)... Mich. (PRWEB) , ... May 27, 2020 , ... The ... Covid-19 curve and Howell Michigan, Fowlerville Michigan , and Ann Arbor Michigan. ... seeing all high-risk patients within the clinic and at the hospital. We have been ...
(Date:5/26/2020)... , ... May 26, 2020 ... ... previously unknown mechanism through which certain infections can impact the brain causing ... Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) and PANS (Pediatric Acute-onset Neuropsychiatric ...
Breaking Medicine News(10 mins):
(Date:5/28/2020)... ... May 28, 2020 , ... When Sean Fitzgerald was in ... were able to help provide the physical care services needed to keep older adults ... the houses themselves. Now Fitzgerald is pleased to be in a position to help ...
(Date:5/28/2020)... ... May 28, 2020 , ... May is Talking is ... parents and champions who care about them. The focus of Power to Decide’s #TalkingIsPower ... lives of young people. Power to Decide’s Mackenzie Piper, MPH, CHES, provides five strategies ...
(Date:5/28/2020)... Tenn. (PRWEB) , ... May 28, 2020 , ... ... care continuum, The Beryl Institute releases its latest white paper, Caring for our ... evidence of successful patient experience practices in pediatric settings and highlights key findings ...
Breaking Medicine Technology:
Cached News: